Critical Role of Iron in Epoetin Alfa Treatment of Chemotherapy-Associated Anemia

被引：3
|
作者：
Gross, Irwin [1 ,2 ]
Farmer, Shannon [3 ,4 ]
Hofmann, Axel [3 ,4 ,5 ]
Ozawa, Sherri [6 ]
Shander, Aryeh [6 ,7 ]
Aapro, Matti [8 ]
机构：
[1] Eastern Maine Med Ctr, Bangor, ME 04401 USA
[2] Accumen, San Diego, CA 92121 USA
[3] Univ Western Australia, Nedlands, WA 6009, Australia
[4] Curtin Univ, Perth, WA, Australia
[5] Univ Zurich, Zurich, Switzerland
[6] Englewood Hosp & Med Ctr, Englewood, NJ USA
[7] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[8] IMO Clin Genolier, Genolier, Switzerland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 31期
关键词：
RECOMBINANT-HUMAN-ERYTHROPOIETIN; STIMULATING AGENTS; CANCER-PATIENTS; OPEN-LABEL; IV IRON; THROMBOSIS; MULTICENTER; DEFICIENCY; MORTALITY;
D O I：
10.1200/JCO.2016.67.7377
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3819 / +
页数：3
相关论文
共 50 条
  • [31] Recombinant human erythropoietin in chemotherapy-associated anemia
    Cascinu, S
    Catalano, G
    Cellerino, R
    CANCER TREATMENT REVIEWS, 1995, 21 (06) : 553 - 564
  • [32] Treatment of chemotherapy-associated cardiomyopathy
    Cai, Amanda W.
    Taylor, Marian H.
    Ramu, Bhavadharini
    CURRENT OPINION IN CARDIOLOGY, 2019, 34 (03) : 296 - 302
  • [33] Epoetin Alfa and Darbepoetin Alfa in Clinical Practice in Patients With Chemotherapy Induced Anemia in the Netherlands (EVALUATE)
    van Groeningen, C. J.
    Kok, T. C.
    Biesma, B.
    Melissant, C. F.
    de Klerk, G.
    Brok, R. G. P. M.
    Lahaye, M.
    Milek, R. L. B.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S237 - S237
  • [34] Epoetin Alfa Biosimilar Treatment for Chemotherapy-Induced Anemia in Current Oncology and Hematology Practice: An Iron Supplementation Subanalysis of the Synergy Study
    Scotte, Florian
    Laribi, Kamel
    Gisselbrecht, Christian
    Spaeth, Dominique
    Kasdaghli, Emna
    Albrand, Helene
    Leutenegger, Eric
    Ray-Coquard, Isabelle
    BLOOD, 2015, 126 (23)
  • [35] EPOETIN ALFA AND DARBEPOETIN ALFA DOSING PATTERNS AND COSTS IN CHEMOTHERAPY-INDUCED ANEMIA INPATIENTS
    Lafeuille, M. H.
    Forlenza, J. B.
    Khan, A.
    Laliberte-Auger, F.
    Lefebvre, P.
    VALUE IN HEALTH, 2012, 15 (04) : A213 - A214
  • [36] Epoetin alfa for treatment of anemia in HIV-infected patients
    Bellman, P
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 39 (03) : 376 - 377
  • [37] Serum hepcidin levels predict response to intravenous iron and darbepoetin in chemotherapy-associated anemia
    Steensma, David P.
    Sasu, Barbra J.
    Sloan, Jeff A.
    Tomita, Dianne K.
    Loprinzi, Charles L.
    BLOOD, 2015, 125 (23) : 3669 - 3671
  • [38] Treatment of cancer-related anemia with epoetin alfa: a review
    Ferrario, E
    Ferrari, L
    Bidoli, P
    De Candis, D
    Del Vecchio, M
    De Dosso, S
    Buzzoni, R
    Bajetta, E
    CANCER TREATMENT REVIEWS, 2004, 30 (06) : 563 - 575
  • [39] ECONOMIC EVALUATION OF EPOETIN ALFA HEXAL (BINOCRIT) COMPARED TO DARBEPOETIN ALFA (ARANESP) IN THE TREATMENT OF CHEMOTHERAPY INDUCED ANEMIA (CIA) IN GERMANY
    Turner, M.
    Walsh, K.
    Whitehouse, J.
    VALUE IN HEALTH, 2013, 16 (07) : A399 - A399
  • [40] Treatment of anemia with epoetin alfa 80,000 U QW in cancer patients receiving chemotherapy
    Tarabay, G
    Braly, P
    Baker, JJ
    Williams, D
    Waltzman, RJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 780S - 780S
12345